MX9202634A - USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B. - Google Patents

USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B.

Info

Publication number
MX9202634A
MX9202634A MX9202634A MX9202634A MX9202634A MX 9202634 A MX9202634 A MX 9202634A MX 9202634 A MX9202634 A MX 9202634A MX 9202634 A MX9202634 A MX 9202634A MX 9202634 A MX9202634 A MX 9202634A
Authority
MX
Mexico
Prior art keywords
treatment
hepatitis
oxatiolane
nucleoside analogs
nucleoside analogues
Prior art date
Application number
MX9202634A
Other languages
Spanish (es)
Inventor
Bernard Belleau
Nghe Nguyen-Ba
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Priority to MX9202634A priority Critical patent/MX9202634A/en
Publication of MX9202634A publication Critical patent/MX9202634A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe el uso de un compuesto de la fórmula (I) o de un derivado farmacéuticamente aceptable del mismo, en la fabricación de un medicamento para el tratamiento de hepatitis B. La presente invención se refiere al uso de análogos de nucleósidos en el tratamiento de infecciones virales. Más específicamente, se refiere al uso de análogos de nucleósido de 1,3-oxatiolano, en el tratamiento de hepatitis, en particular hepatitis B.The use of a compound of formula (I) or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the treatment of hepatitis B is described. The present invention relates to the use of nucleoside analogues in the treatment of viral infections. More specifically, it refers to the use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis, in particular hepatitis B.

MX9202634A 1992-06-03 1992-06-03 USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B. MX9202634A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9202634A MX9202634A (en) 1992-06-03 1992-06-03 USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9202634A MX9202634A (en) 1992-06-03 1992-06-03 USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B.

Publications (1)

Publication Number Publication Date
MX9202634A true MX9202634A (en) 1994-01-31

Family

ID=19744050

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202634A MX9202634A (en) 1992-06-03 1992-06-03 USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B.

Country Status (1)

Country Link
MX (1) MX9202634A (en)

Similar Documents

Publication Publication Date Title
MD1224C2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES2157929T3 (en) BETA-D-DIOXOLANO-NUCLEOSIDOS ENANTIOMERAMENTLY PURE.
IL101836A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives
CZ283765B6 (en) (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1h) -pyrimidin-2-one a mixture containing such compound, pharmaceutical composition in which the compound is comprised, the compound per se or the mixture thereof for use in therapy and the use of the compound when preparing medicaments
NO20023852D0 (en) Nucleoside analogs with carboxamidine-modified bicyclic base
ATE115958T1 (en) NUCLEOSIDES AND NUCLEOSIDE ANALOGUES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PREPARATION OF THE INGREDIENTS.
MX9403380A (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
ES2083668T5 (en) ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS.
ES2108969T3 (en) USE OF DIDESOXINUCLEOSID ANALOGS IN THE TREATMENT OF VIRAL INFECTIONS.
DE60036862D1 (en) SYNERGISTIC INHIBITION OF VIRAL REPLICATION BY LONG-CHAINED HYDROCARBONS AND NUCLEOSIDE ANALOGS
MX9202634A (en) USE OF 1,3-OXATIOLANE NUCLEOSIDE ANALOGS IN THE TREATMENT OF HEPATITIS B.
KR910700054A (en) Methods and compositions for the prevention and treatment of hepatitis B virus infection
AR024537A1 (en) SYNERGIC COMBINATION FOR THE TREATMENT OF VIRAL MEDIUMED DISEASES
MX9203068A (en) ORALALLY ACTIVE ACTIVIRAL COMPOUNDS.
ES8308335A1 (en) Antiviral deoxyuridine compounds.
DE60022047D1 (en) ANTIVIRAL THERAPY
ES2169117T3 (en) USE OF DERIVATIVES OF 2-AMINOPURIN IN THE TREATMENT AND PROFILAXIS OF INFECTION BY VIRUS 7 OF THE HUMAN HERPES.
ATE270886T1 (en) ANTIVIRAL THERAPY
UY25022A1 (en) USE OF COMPOUNDS ANALOGED TO 1,3-OXATIOLANES - NUCLEOSIDES IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEPATITIS B